Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
暂无分享,去创建一个
J. Frazier | C. Edwards | A. Bendele | E. Chlipala | W. Rich | G. Sennello | J. Scherrer | Jon Scherrer | Carl K. Edwards | Alison M. Bendele | Alison M. Bendele | C. K. Edwards